tirzepatide 2.5 mg 0.5 ml solution auto injector Mounjaro (Tirzepatide) Injection 5 mg/0.5 Syringes — Mountainside Medical Mounjaro (Tirzepatide) Weight Loss Injection

The Wegovy tablet, made by Novo Nordisk, became the first GLP-1 pill for weight loss to be approved by the UKs medicines regulator last month

These gastrointestinal side effects can lead to dehydration and potentially acute kidney injury, especially in patients taking medications that affect kidney function

In the study, also funded by Novo Nordisk, researchers from the University of Southern Denmark suggest a link between GLP-1RAs and a reduction in use of triptan-class medications by women who experience migraine

C9orf72 hexanucleotide repeat expansions impair microglial response in ALS

Outcomes vary by patient

Patients may be able to achieve the same therapeutic effect at lower doses and therefore reduce their risk of side effects